Bluesky Facebook Reddit Email

Elderly patients denied best treatment for fear of side effects

A study involving 83 elderly women found that patients with depression, limited autonomy, and institutional living are at risk of toxicity and reduced treatment effectiveness. Dr. Gilles Freyer's research aims to evaluate risks and benefits for elderly patients with advanced ovarian cancer.

European trial finds old lung cancer treatment may still be best

A new phase III multi-national European trial involving 618 patients with advanced non small-cell lung cancer found that cisplatin and paclitaxel improved survival rates compared to carboplatin and paclitaxel. The study suggests that cisplatin-based chemotherapy remains the preferred standard treatment for lung cancer in Europe.

Jefferson scientists find Cox-2 may play role in some brain tumors

Researchers at Thomas Jefferson University found that COX-2 expression is higher than normal in meningioma and pituitary macroadenomas, with more aggressive disease associated with greater enzyme presence. The study opens up opportunities for designing potential therapies against brain tumors.

The Lancet Oncology and The Lancet Infectious Diseases

A recent report highlights nuclear fallout in the US from Cold War testing, which increases cancer incidence and affects global populations. The editorial also critiques South Africa's delay in providing antiretroviral treatment to pregnant women with HIV.

CalDigit TS4 Thunderbolt 4 Dock

CalDigit TS4 Thunderbolt 4 Dock simplifies serious desks with 18 ports for high-speed storage, monitors, and instruments across Mac and PC setups.